Amputation and phantom limb pain: what regional anesthesia can and cannot prevent
Stem
A 67-year-old man, 92 kg, with diabetes and peripheral vascular disease is scheduled for below-knee amputation of a gangrenous right foot. He has had severe rest pain for 3 months, now on oxycodone 10 mg every 6 hours, and takes aspirin and clopidogrel (last dose this morning) for a recent femoral stent. He asks, "Can you stop me getting phantom pain?"
Question
What is your anesthetic and analgesic plan, and what do you tell him?
Ideal answer
HeadlinePerineural catheters for the first days and his opioid continued; I tell him honestly this controls surgical pain but has not been shown to prevent phantom pain.
- No neuraxial today, because clopidogrel taken this morning rules it out; superficial, compressible blocks remain possible with ultrasound.
- Popliteal sciatic and saphenous catheters, sedation or general, because catheters lower pain scores and morphine needs after amputation.1
- Continue his baseline oxycodone, add acetaminophen and ketamine, because he is opioid tolerant and preoperative pain predicts worse outcomes.2
- Set honest expectations, because phantom pain affects most amputees, and no perioperative drug or block reliably prevents it.3,2
- Plan follow-up and rehabilitation early, including mirror therapy and a pain clinic referral if pain persists.3
Watch for: catheter failure, delirium, and pain in the absent limb versus pain at the wound.
Breaking down the answer
- The evidence on prevention — 20 trials at 6 months or later: epidural or perineural local anesthetic, ketamine, gabapentin and calcitonin did not reliably prevent phantom or stump pain; certainty is low.2 Changes if: future trials of memantine, which remains under study.
- Epidural signal is fragile — pooled epidural bupivacaine-opioid trials gave an odds ratio of 0.56, but restricting to low-risk-of-bias trials removed the effect (0.80).2
- Perineural catheters — infusions for 3–5 days showed no prevention benefit (odds ratio 0.86),2 but improve acute pain and reduce morphine.1
- Phantom versus residual limb pain — phantom pain is felt in the missing part, often distal, burning or cramping; residual limb pain comes from neuroma, ischemia, infection or skin breakdown and is treated differently.3
- Mechanism — cortical and thalamic reorganization plus peripheral ectopic firing from dorsal root ganglia and neuromas, with NMDA-mediated central sensitization.3
Follow-up question
On day 5 the catheters are out. He describes burning and cramping in toes that are no longer there, worse at night; the wound looks healthy. He asks what can be done. What do you offer?
Follow-up answer
HeadlineThis is phantom limb pain; I acknowledge it is real and common and explain that treatment combines medicines, therapy and time.
I examine the residual limb to exclude neuroma, infection or ischemia. Drug evidence is modest: gabapentinoids, amitriptyline and ketamine are used but most medications disappoint.3 Calcitonin has some support for newly developed phantom pain.1 I start mirror therapy with physiotherapy, and plan a pain clinic referral; spinal cord or dorsal root ganglion stimulation and targeted muscle reinnervation are options for refractory pain.3 It usually lessens over the first 6 months.3
Pitfalls that cost points
- Delaying surgery for days to give a "preemptive" epidural; the trials do not justify prolonging ischemic rest pain.2
- Treating all post-amputation pain as phantom pain and missing an ischemic or infected stump.
- Stopping his baseline opioid because "the source of pain is gone."
Rapid-fire
Q: How common is phantom limb pain? A: Reported in 50–80% of amputees;3 one review gives 46–86%, peaking at 1 month and 1 year.2
Q: What is telescoping? A: The sense that the phantom limb shortens or shrinks over time.3
Q: Can phantom pain follow non-limb surgery? A: Yes, after removal of a breast, eye, tongue, rectum or teeth.3
Q: Why did older reviews favor epidurals? A: Small, poorly blinded trials; restricting to low-risk-of-bias studies removed the effect.2
Numbers to know
| Item | Value |
|---|---|
| Phantom pain prevalence | 50–80% (46–86%)3,2 |
| Epidural prevention, all vs low-bias trials | OR 0.56 vs 0.80 (not significant)2 |
| Perineural catheter prevention | OR 0.86 (not significant)2 |
| Typical catheter infusion | 72 h; trials 3–5 days3,2 |
Links
- Femoral, adductor canal and popliteal blocks, Neuraxial blocks and anticoagulants (ASRA), Acute pain in the opioid-tolerant patient, crps, The patient with a spinal cord stimulator or intrathecal pump
- ASRA guidelines on regional anesthesia in patients on antithrombotic therapy (2025)
Sources
- 1.Pharmacological therapies for pain management in patients with amputation: a systematic review and network meta-analysis · Pain Res Manag (PMC13581055), 2026 · pmc.ncbi.nlm.nih.govUmbrella review; quotes Laloo 2021 on perineural catheters and Neumüller 2023 on calcitonin.
- 2.The role of preemptive perioperative analgesia in prevention of chronic phantom pain: a systematic review and meta-analysis · Med J Islam Repub Iran (PMC12516416), 2025 · pmc.ncbi.nlm.nih.gov20 RCTs, outcomes at 6 months or later; low certainty.
- 3.Phantom Limb Pain · OpenAnesthesia (IARS), 2024 · openanesthesia.org
Facts on this page were checked against these sources on Nov 2, 2026. Guidelines change; confirm doses against current institutional protocols.